1. Home
  2. PHAR vs MAX Comparison

PHAR vs MAX Comparison

Compare PHAR & MAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • MAX
  • Stock Information
  • Founded
  • PHAR 1988
  • MAX 2014
  • Country
  • PHAR Netherlands
  • MAX United States
  • Employees
  • PHAR N/A
  • MAX N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • MAX Industrial Machinery/Components
  • Sector
  • PHAR Health Care
  • MAX Industrials
  • Exchange
  • PHAR Nasdaq
  • MAX Nasdaq
  • Market Cap
  • PHAR 618.3M
  • MAX 604.9M
  • IPO Year
  • PHAR N/A
  • MAX 2020
  • Fundamental
  • Price
  • PHAR $8.20
  • MAX $11.77
  • Analyst Decision
  • PHAR Strong Buy
  • MAX Buy
  • Analyst Count
  • PHAR 3
  • MAX 8
  • Target Price
  • PHAR $27.00
  • MAX $22.00
  • AVG Volume (30 Days)
  • PHAR 5.6K
  • MAX 375.8K
  • Earning Date
  • PHAR 03-13-2025
  • MAX 02-24-2025
  • Dividend Yield
  • PHAR N/A
  • MAX N/A
  • EPS Growth
  • PHAR N/A
  • MAX N/A
  • EPS
  • PHAR N/A
  • MAX 0.19
  • Revenue
  • PHAR $285,745,000.00
  • MAX $681,230,000.00
  • Revenue This Year
  • PHAR $20.08
  • MAX $122.48
  • Revenue Next Year
  • PHAR $9.22
  • MAX $32.24
  • P/E Ratio
  • PHAR N/A
  • MAX $62.34
  • Revenue Growth
  • PHAR 30.64
  • MAX 72.47
  • 52 Week Low
  • PHAR $6.65
  • MAX $10.21
  • 52 Week High
  • PHAR $13.20
  • MAX $25.78
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 36.29
  • MAX 55.43
  • Support Level
  • PHAR $8.49
  • MAX $11.02
  • Resistance Level
  • PHAR $9.35
  • MAX $11.73
  • Average True Range (ATR)
  • PHAR 0.55
  • MAX 0.45
  • MACD
  • PHAR -0.17
  • MAX 0.09
  • Stochastic Oscillator
  • PHAR 12.14
  • MAX 75.00

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About MAX MediaAlpha Inc.

MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.

Share on Social Networks: